305 related articles for article (PubMed ID: 22226682)
1. Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei.
Kieft R; Stephens NA; Capewell P; MacLeod A; Hajduk SL
Mol Biochem Parasitol; 2012 May; 183(1):8-14. PubMed ID: 22226682
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.
Kieft R; Capewell P; Turner CM; Veitch NJ; MacLeod A; Hajduk S
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16137-41. PubMed ID: 20805508
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of serum resistance associated protein in Trypanosoma brucei rhodesiense.
Milner JD; Hajduk SL
Mol Biochem Parasitol; 1999 Nov; 104(2):271-83. PubMed ID: 10593181
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.
Bullard W; Kieft R; Capewell P; Veitch NJ; Macleod A; Hajduk SL
Virulence; 2012; 3(1):72-6. PubMed ID: 22286709
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of human high-density-lipoprotein-resistant Trypanosoma brucei brucei.
Faulkner SD; Oli MW; Kieft R; Cotlin L; Widener J; Shiflett A; Cipriano MJ; Pacocha SE; Birkeland SR; Hajduk SL; McArthur AG
Eukaryot Cell; 2006 Aug; 5(8):1276-86. PubMed ID: 16896212
[TBL] [Abstract][Full Text] [Related]
6. Serum resistance-associated protein blocks lysosomal targeting of trypanosome lytic factor in Trypanosoma brucei.
Oli MW; Cotlin LF; Shiflett AM; Hajduk SL
Eukaryot Cell; 2006 Jan; 5(1):132-9. PubMed ID: 16400175
[TBL] [Abstract][Full Text] [Related]
7. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
8. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.
Capewell P; Cooper A; Clucas C; Weir W; Macleod A
Parasitology; 2015 Feb; 142 Suppl 1(Suppl 1):S108-19. PubMed ID: 25656360
[TBL] [Abstract][Full Text] [Related]
9. Developmentally regulated sensitivity of Trypanosoma brucei brucei to the cytotoxic effects of human high-density lipoprotein.
Moore DR; Smith A; Hager KM; Waldon R; Esko JD; Hajduk SL
Exp Parasitol; 1995 Sep; 81(2):216-26. PubMed ID: 7556564
[TBL] [Abstract][Full Text] [Related]
10. Isolation and analysis of the genetic diversity of repertoires of VSG expression site containing telomeres from Trypanosoma brucei gambiense, T. b. brucei and T. equiperdum.
Young R; Taylor JE; Kurioka A; Becker M; Louis EJ; Rudenko G
BMC Genomics; 2008 Aug; 9():385. PubMed ID: 18700033
[TBL] [Abstract][Full Text] [Related]
11. Trypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei.
Greene AS; Hajduk SL
J Biol Chem; 2016 Feb; 291(6):3063-75. PubMed ID: 26645690
[TBL] [Abstract][Full Text] [Related]
12. Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
Capewell P; Veitch NJ; Turner CM; Raper J; Berriman M; Hajduk SL; MacLeod A
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1287. PubMed ID: 21909441
[TBL] [Abstract][Full Text] [Related]
13. Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity.
Higgins MK; Tkachenko O; Brown A; Reed J; Raper J; Carrington M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1905-10. PubMed ID: 23319650
[TBL] [Abstract][Full Text] [Related]
14. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
Lecordier L; Vanhollebeke B; Poelvoorde P; Tebabi P; Paturiaux-Hanocq F; Andris F; Lins L; Pays E
PLoS Pathog; 2009 Dec; 5(12):e1000685. PubMed ID: 19997494
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Trypanosoma brucei gambiense resistance to human serum.
Uzureau P; Uzureau S; Lecordier L; Fontaine F; Tebabi P; Homblé F; Grélard A; Zhendre V; Nolan DP; Lins L; Crowet JM; Pays A; Felu C; Poelvoorde P; Vanhollebeke B; Moestrup SK; Lyngsø J; Pedersen JS; Mottram JC; Dufourc EJ; Pérez-Morga D; Pays E
Nature; 2013 Sep; 501(7467):430-4. PubMed ID: 23965626
[TBL] [Abstract][Full Text] [Related]
16. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum.
Smith AB; Hajduk SL
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10262-6. PubMed ID: 7479764
[TBL] [Abstract][Full Text] [Related]
17. Mutual self-defence: the trypanolytic factor story.
Pays E; Vanhollebeke B
Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance.
Symula RE; Beadell JS; Sistrom M; Agbebakun K; Balmer O; Gibson W; Aksoy S; Caccone A
PLoS Negl Trop Dis; 2012; 6(7):e1728. PubMed ID: 22802982
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding.
DeJesus E; Kieft R; Albright B; Stephens NA; Hajduk SL
PLoS Pathog; 2013; 9(4):e1003317. PubMed ID: 23637606
[TBL] [Abstract][Full Text] [Related]
20. Activity of human trypanosome lytic factor in mice.
Barker C; Barbour KW; Berger FG; Hajduk SL
Mol Biochem Parasitol; 2001 Oct; 117(2):129-36. PubMed ID: 11606222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
